1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 and under
Sponsor: Other
Protocol IDs: LAL-BR/2001, NCT00526175
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: LAL-AR/2003, NCT00853008
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 55 and under
Sponsor: Other
Protocol IDs: LAL Ph-2008, NCT01491763
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 60
Sponsor: Other
Protocol IDs: LAL-AR/2011, NCT01540812
|
|
6.
|
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NCI
Protocol IDs: COG-ANHL1131, ANHL1131, NCT01595048
|
|
7.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: COG-AALL1131, AALL1131, NCT01406756
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: 06-254, NCT00476190
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 to 50
Sponsor: NCI
Protocol IDs: OSU-08066, OSU 08066, 2008C0112, DFCI-06254, NCT01005758
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200916901, UCDCC#218, NCT00895310
|
|
11.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: Child
Sponsor: Other
Protocol IDs: POWH-CRE-2008.077-T, CRE-2008.077-T, NCT00707083
|
Mobile | Español
